(Webinar Held: September 16, 2020) Developed in collaboration with Deloitte Consulting LLP, the US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19 report provides insights into the role that the supply chain played in ensuring delivery and availability of medicines during the first 90 days of the COVID-19 pandemic.
In this webinar, you will receive an in-depth look at key findings from the report, including:
Rob Jacoby, Principal, Deloitte Consulting LLP
Matt Heim, Senior Manager, Deloitte Consulting LLP
Cinthya Fernandez Preda, Manager, Deloitte Consulting LLP
Perry Fri, Executive Vice President, Industry Relations, Membership & Education, HDA; COO, HDA Research Foundation (Moderator)